GSK Hit With Thalidomide Birth Defect Suit

Law360, New York (August 9, 2012, 7:23 PM EDT) -- A group of 11 plaintiffs sued GlaxoSmithKline PLC and other pharmaceutical companies in Pennsylvania court Thursday, alleging they suffered birth defects after their mothers took the morning sickness drug thalidomide in the late 1950s and early 1960s.

Thalidomide — which was developed by German pharmaceutical company Gruenenthal GmbH, also named as a defendant — was never approved for distribution by the U.S. Food and Drug Administration, but the plaintiffs say predecessor companies of GSK and Sanofi-Aventis U.S. LLC distributed millions of doses of thalidomide to doctors...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.